Metraipolis › archive › dc_96db0ac9cb83

AMT-130 gene therapy: a promising disease-modifying approach for Huntington's disease — Europe PMC PMID:41497150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41497150
DOI
10.1097/ms9.0000000000004574
License (as archived)
solo-consultazione
Archived
2026-11-07T18:13:57.240Z
SHA-256 of the archived text
040fb1d419e771a311b34588aa9395f98453352eaba793897c5508de5af76a4a
Stable URL of this page
https://metraipolis.com/documento/dc_96db0ac9cb83

How to cite

AMT-130 gene therapy: a promising disease-modifying approach for Huntington's disease — Europe PMC PMID:41497150 — Europe PMC (en), https://europepmc.org/article/MED/41497150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96db0ac9cb83 (Metraipolis archive dc_96db0ac9cb83, sha256 040fb1d419e771a311b34588aa9395f98453352eaba793897c5508de5af76a4a)
BibTeX
@misc{dc96db0ac9cb83,
  title = {AMT-130 gene therapy: a promising disease-modifying approach for Huntington's disease — Europe PMC PMID:41497150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41497150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96db0ac9cb83; sha256 040fb1d419e771a311b34588aa9395f98453352eaba793897c5508de5af76a4a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41497150. Agents can read the archived copy with the MCP tool read_document.